HALO Precision Diagnostics

Early detection saves lives.
Let’s start with yours.

HALO delivers personalized insights into the leading causes of death — cancer, cardiac disease, and neurodegenerative conditions.

Find a HALO Location Contact Us

Watch the full video with sound →

Breast CancerProstate CancerPancreatic CancerLung CancerColorectal CancerOvarian CancerHereditary Cancer RiskCoronary Artery DiseaseStroke RiskAlzheimer’s DiseaseDementiaBPH Breast CancerProstate CancerPancreatic CancerLung CancerColorectal CancerOvarian CancerHereditary Cancer RiskCoronary Artery DiseaseStroke RiskAlzheimer’s DiseaseDementiaBPH

How it works

Getting started is easy

Visit a HALO partner center

Come in for your imaging appointment and complete a simple Family History Questionnaire — it takes minutes.

Meet your Patient Navigator

A navigator reviews your history and, if indicated, arranges genetic testing. Most insurance plans cover it with no out-of-pocket cost.

Follow your personalized pathway

Review results with a clinician and start a screening plan built around your personal risk — so problems are found early, when they’re most treatable.

HALO is focusing on early detection for diseases causing approximately half of deaths in the US every year¹

Cancer

Early detection gives you more choices for treatment and a better chance to live a longer, healthier life

Every year in the US, over 600,000 people die of cancer². Early detection of cancer can have a major impact. Data from the National Cancer Institute shows that for the five leading types of cancer that cause death (lung, colorectal, pancreatic, breast, and prostate), people diagnosed at an early stage have an average survival rate that is five times higher than those diagnosed at an advanced stage³.

Learn More

Cardiovascular Disease

Early detection leads to better outcomes, fewer emergencies, and a longer, healthier life

The earlier cardiovascular disease is found, the more can be done to prevent serious problems. Many people experience their first cardiac event without warning, and in some cases, it is fatal⁴. Early detection can include blood pressure screening, cholesterol testing, or advanced imaging. Preventing just one heart attack or stroke through early detection can save tens of thousands of dollars in healthcare costs and add years of life⁶.

Coming 2027

Dementia

Early detection of dementia empowers patients and families to take action

While dementia cannot be cured, early detection allows individuals to begin treatment sooner, adopt lifestyle changes that may help slow cognitive decline, and make informed plans for their future⁶. A recent report identified modifiable risk factors that account for nearly 40% of all dementia⁷. For individuals diagnosed with Alzheimer’s disease, certain medications have been shown to improve cognition, improve activities of daily living and decrease mortality⁸.

Coming 2027

We are HALO

A leading precision diagnostics company expanding access to personalized, proactive healthcare. We’re turning imaging centers into next-generation diagnostic hubs — starting with cancer and expanding to cardiovascular disease and dementia.

1 in 8 women

will be diagnosed with breast cancer in their lifetime

1 in 6 people

meet genetic testing criteria, but only a small fraction have had genetic testing

1 in 9 men

will be diagnosed with prostate cancer in their lifetime

Leading cause of death

for both men and women is cardiovascular disease

HALO Pathways available at partner centers across the nation

Find a HALO site near you — click a pin for details and directions.

HALO Pathways HALO Prostate HALO Research Imaging

See All Locations & Details

HALO Leadership — Seasoned Business, Technology and Clinical Executives

Our leadership team brings together deep expertise across imaging, clinical care, and technology — driving innovation that makes care more proactive, data-driven, and patient-centered.

Michael Uhl

Chief Executive Officer

20+ years of leadership creating $100B+ in tech-based growth transactions at McKinsey.

Brian Axe

Chief Product Officer/Investors

Launched Google’s AdSense business; Google Founders Award recipient; serial entrepreneur.

Dr. John F. Feller

Chief Medical Officer

Stanford trained diagnostic radiologist; founding partner of Desert Medical Imaging.

Bernadette M. Greenwood, RT(R)(MR)(ARRT), PhD(c)

Research & Therapeutics

PhD(c) prostate MRI researcher; developed and led the first human case of MRI-guided focal laser therapy in 2010.

Jeff Gerard

Senior Advisor

Former President of Sutter Health, leading growth and transformation of large health organizations.

Tichelle Lyons

Revenue Cycle

CPC (Certified Professional Coder)-certified RCM (Revenue Cycle Management) leader with 10+ years across diagnostics; built AI-driven workflows, boosting collections 30%.

Meet the Full Team

Patient Story

Meet Paul

How HALO helped a patient get their health back on track

At the age of 48, Paul injured his knee and was sent for an MRI. While filling out his paperwork, he also completed a Family History Questionnaire and included that his father died of pancreatic cancer at 45.

After his MRI, he met with a Patient Navigator to review his family history. Genetic testing identified a variant in the PALB2 gene — associated with increased risk of breast, ovarian, and pancreatic cancer. Paul worked with his physician to begin appropriate cancer screenings, and his family members were able to pursue testing and earlier screening too.

Learn About Genetic Testing